IL23A and inflammatory bowel disease: The anti-inflammatory effects of probiotics in IBD might be a consequence of downregulation of IL-17 production and related proinflammatory Th17-secreted cytokines such as IL-23, TGF-β, IL-1β, IL-6, TNF-α, IFN-γ, and IL-12.